FDA Pushes Selective Safety Data Collection

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

FDA Pushes Selective Safety Data Collection

J.W. Schomisch

July 25, 2025 at 02:01 PM EST

The FDA is looking for more industry buy-in to using selective safety data collection (SSDC) in clinical trials for drugs with well-characterized safety profiles. “The community does not know the extent to which sponsors have applied SSDC to clinical trials, the therapeutic areas, the settings (i.e., pre-approval or post-approval), the challenges sponsors have encountered (in... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

FDA Pushes Selective Safety Data Collection

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT